 Heart Diseases
"Heart Diseases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Pathological conditions involving the HEART including its structural and functional abnormalities.
| Descriptor ID |
D006331
|
| MeSH Number(s) |
C14.280
|
| Concept/Terms |
Heart Diseases- Heart Diseases
- Disease, Heart
- Diseases, Heart
- Heart Disease
- Cardiac Diseases
- Cardiac Disease
- Disease, Cardiac
- Diseases, Cardiac
|
Below are MeSH descriptors whose meaning is more general than "Heart Diseases".
Below are MeSH descriptors whose meaning is more specific than "Heart Diseases".
This graph shows the total number of publications written about "Heart Diseases" by people in this website by year, and whether "Heart Diseases" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1991 | 1 | 0 | 1 | | 1992 | 0 | 1 | 1 | | 1993 | 1 | 2 | 3 | | 1994 | 2 | 0 | 2 | | 1995 | 4 | 0 | 4 | | 1996 | 1 | 2 | 3 | | 1997 | 4 | 2 | 6 | | 1998 | 4 | 2 | 6 | | 1999 | 2 | 0 | 2 | | 2000 | 2 | 1 | 3 | | 2001 | 5 | 2 | 7 | | 2002 | 1 | 3 | 4 | | 2003 | 0 | 3 | 3 | | 2004 | 4 | 3 | 7 | | 2005 | 6 | 3 | 9 | | 2006 | 8 | 5 | 13 | | 2007 | 7 | 3 | 10 | | 2008 | 13 | 2 | 15 | | 2009 | 4 | 3 | 7 | | 2010 | 7 | 4 | 11 | | 2011 | 9 | 3 | 12 | | 2012 | 11 | 1 | 12 | | 2013 | 9 | 6 | 15 | | 2014 | 12 | 4 | 16 | | 2015 | 18 | 2 | 20 | | 2016 | 9 | 2 | 11 | | 2017 | 14 | 0 | 14 | | 2018 | 9 | 3 | 12 | | 2019 | 17 | 5 | 22 | | 2020 | 6 | 1 | 7 |
To return to the timeline, click here.
Below are the most recent publications written about "Heart Diseases" by people in Profiles.
-
Shah PB, Welt FGP, Mahmud E, Phillips A, Kleiman NS, Young MN, Sherwood M, Batchelor W, Wang DD, Davidson L, Wyman J, Kadavath S, Szerlip M, Hermiller J, Fullerton D, Anwaruddin S. Triage considerations for patients referred for structural heart disease intervention during the COVID-19 pandemic: An ACC/SCAI position statement. Catheter Cardiovasc Interv. 2020 09 01; 96(3):659-663.
-
Khazanie P, Wynia MK, Dickert NW. Forced Choices: Ethical Challenges in Cardiology During the COVID-19 Pandemic. Circulation. 2020 07 21; 142(3):194-196.
-
Derington CG, Heath LJ, Kao DP, Delate T. Validation of algorithms to identify elective percutaneous coronary interventions in administrative databases. PLoS One. 2020; 15(4):e0231100.
-
Shah PB, Welt FGP, Mahmud E, Phillips A, Kleiman NS, Young MN, Sherwood M, Batchelor W, Wang DD, Davidson L, Wyman J, Kadavath S, Szerlip M, Hermiller J, Fullerton D, Anwaruddin S. Triage Considerations for Patients Referred for Structural Heart Disease Intervention During the COVID-19 Pandemic: An ACC/SCAI Position Statement. JACC Cardiovasc Interv. 2020 06 22; 13(12):1484-1488.
-
O'Meara E, McDonald M, Chan M, Ducharme A, Ezekowitz JA, Giannetti N, Grzeslo A, Heckman GA, Howlett JG, Koshman SL, Lepage S, Mielniczuk LM, Moe GW, Swiggum E, Toma M, Virani SA, Zieroth S, De S, Matteau S, Parent MC, Asgar AW, Cohen G, Fine N, Davis M, Verma S, Cherney D, Abrams H, Al-Hesayen A, Cohen-Solal A, D'Astous M, Delgado DH, Desplantie O, Estrella-Holder E, Green L, Haddad H, Harkness K, Hernandez AF, Kouz S, LeBlanc MH, Lee D, Masoudi FA, McKelvie RS, Rajda M, Ross HJ, Sussex B. CCS/CHFS Heart Failure Guidelines: Clinical Trial Update on Functional Mitral Regurgitation, SGLT2 Inhibitors, ARNI in HFpEF, and Tafamidis in Amyloidosis. Can J Cardiol. 2020 02; 36(2):159-169.
-
Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Delling FN, Djousse L, Elkind MSV, Ferguson JF, Fornage M, Khan SS, Kissela BM, Knutson KL, Kwan TW, Lackland DT, Lewis TT, Lichtman JH, Longenecker CT, Loop MS, Lutsey PL, Martin SS, Matsushita K, Moran AE, Mussolino ME, Perak AM, Rosamond WD, Roth GA, Sampson UKA, Satou GM, Schroeder EB, Shah SH, Shay CM, Spartano NL, Stokes A, Tirschwell DL, VanWagner LB, Tsao CW. Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association. Circulation. 2020 03 03; 141(9):e139-e596.
-
Chaves G, Turk-Adawi K, Supervia M, Santiago de Araújo Pio C, Abu-Jeish AH, Mamataz T, Tarima S, Lopez Jimenez F, Grace SL. Cardiac Rehabilitation Dose Around the World: Variation and Correlates. Circ Cardiovasc Qual Outcomes. 2020 01; 13(1):e005453.
-
Farrell AT, Panepinto J, Desai AA, Kassim AA, Lebensburger J, Walters MC, Bauer DE, Blaylark RM, DiMichele DM, Gladwin MT, Green NS, Hassell K, Kato GJ, Klings ES, Kohn DB, Krishnamurti L, Little J, Makani J, Malik P, McGann PT, Minniti C, Morris CR, Odame I, Oneal PA, Setse R, Sharma P, Shenoy S. End points for sickle cell disease clinical trials: renal and cardiopulmonary, cure, and low-resource settings. Blood Adv. 2019 12 10; 3(23):4002-4020.
-
Amigues I, Russo C, Giles JT, Tugcu A, Weinberg R, Bokhari S, Bathon JM. Myocardial Microvascular Dysfunction in Rheumatoid ArthritisQuantitation by 13N-Ammonia Positron Emission Tomography/Computed Tomography. Circ Cardiovasc Imaging. 2019 12; 12(1):e007495.
-
Guida JL, Ahles TA, Belsky D, Campisi J, Cohen HJ, DeGregori J, Fuldner R, Ferrucci L, Gallicchio L, Gavrilov L, Gavrilova N, Green PA, Jhappan C, Kohanski R, Krull K, Mandelblatt J, Ness KK, O'Mara A, Price N, Schrack J, Studenski S, Theou O, Tracy RP, Hurria A. Measuring Aging and Identifying Aging Phenotypes in Cancer Survivors. J Natl Cancer Inst. 2019 12 01; 111(12):1245-1254.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|